KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Gross Margin (2016 - 2025)

Gilead Sciences (GILD) has disclosed Gross Margin for 17 consecutive years, with 79.51% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 40.0% year-over-year to 79.51%, compared with a TTM value of 78.83% through Dec 2025, up 57.0%, and an annual FY2025 reading of 78.83%, up 57.0% over the prior year.
  • Gross Margin was 79.51% for Q4 2025 at Gilead Sciences, roughly flat from 79.8% in the prior quarter.
  • Across five years, Gross Margin topped out at 83.52% in Q3 2021 and bottomed at 63.74% in Q4 2021.
  • Average Gross Margin over 5 years is 77.64%, with a median of 78.27% recorded in 2023.
  • The sharpest move saw Gross Margin tumbled -1743bps in 2021, then surged 1737bps in 2022.
  • Year by year, Gross Margin stood at 63.74% in 2021, then rose by 27bps to 81.11% in 2022, then fell by -13bps to 70.62% in 2023, then grew by 12bps to 79.11% in 2024, then rose by 1bps to 79.51% in 2025.
  • Business Quant data shows Gross Margin for GILD at 79.51% in Q4 2025, 79.8% in Q3 2025, and 78.81% in Q2 2025.